WHO okays two new treatments for curing COVID-19 patients
The World Health Organization approved two new treatments for curing Covid-19 patients on Friday as Omicron cases continued to surge worldwide. WHO experts said arthritis drug baricitinib used with corticosteroids to treat severe or critical Covid patients led to better survival rates and reduced need for ventilators. Experts also recommended synthetic antibody treatment drug Sotrovimab for people with non-serious Covid at highest risk of hospitalization, such as the elderly, people with immunodeficiencies, or chronic diseases such as diabetes. Sotrovimab's benefits for people not at risk of hospitalization were deemed insignificant and the WHO said its effectiveness against new variants like Omicron was still uncertain. The recommendations have been published in British Medical Journal BMJ. Only three other treatments for Covid-19 have received WHO approval, starting with corticosteroids for severely ill patients in September 2020. Read More